tiprankstipranks
Cidara gets $2.8M milestone payment from Mundipharma for MHRA’s Rezzayo approval
PremiumThe FlyCidara gets $2.8M milestone payment from Mundipharma for MHRA’s Rezzayo approval
3M ago
Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults
PremiumPress Releases
Cidara Therapeutics Announces Approval of REZZAYO by the MHRA for the Treatment of Invasive Candidiasis in Adults
3M ago
MHRA approves Cidara Therapeutics’ Rezzayo for invasive candidiasis in adults
PremiumThe Fly
MHRA approves Cidara Therapeutics’ Rezzayo for invasive candidiasis in adults
3M ago
Cidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress
PremiumPress ReleasesCidara Therapeutics to Present New Preclinical Data on Novel Dual-Acting Drug-Fc Conjugates at ESMO Immuno-Oncology Annual Congress
5M ago
Cidara Therapeutics management to meet with Needham
PremiumThe Fly
Cidara Therapeutics management to meet with Needham
5M ago
Cidara Therapeutics management to meet with Needham
PremiumThe Fly
Cidara Therapeutics management to meet with Needham
5M ago
Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
PremiumPress ReleasesCidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
6M ago
H.C. Wainwright sees Cidara’s REZZAYO being approved in Europe after CHMP nod
PremiumThe Fly
H.C. Wainwright sees Cidara’s REZZAYO being approved in Europe after CHMP nod
6M ago
Cidara Therapeutics and Mundipharma receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults(1)
PremiumPress Releases
Cidara Therapeutics and Mundipharma receive positive CHMP opinion for rezafungin for the treatment of Invasive Candidiasis in adults(1)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100